Calgary developed wound gel treats 6000 patients in Ukraine conflict
Calgary-based NanoTess's NanoSALV Catalytic, a catalyst suspended in a lightweight, non-flammable gel applied directly to wounds, has treated 6,000 wounded soldiers and civilians since reaching Ukraine's front lines in June. The gel uses nanomaterials to support the body's natural healing and fight infection-causing microbes, can be flown in by drone, and can be applied by people with limited medical training. It won Health Canada approval in 2022 after initial National Defence funding, and its Ukraine results were presented at the CAN Health Network conference in Toronto.
A Canadian-made treatment that lets wounds heal with little nursing input — one nurse may care for up to 90 patients — could ease mass-casualty and short-staffed care; it was already used for burn injuries from the CFB Wainwright wildfire earlier this month.
Ask about this brief
Answers are written by AI from this brief and can be wrong. Check the original source before you act.
2 free questions a day without an account. Members ask as often as they like, free.
Not medical, legal or immigration advice.
Read the original
News source: Calgary developed wound gel treats 6000 patients in Ukraine conflict (opens in a new tab) — CBC News
